PF-06873600   Click here for help

GtoPdb Ligand ID: 10426

Synonyms: example 10 [WO2018033815] | PF06873600
PDB Ligand
Compound class: Synthetic organic
Comment: PF-06873600 [2] is claimed as example 10 in patent WO2018033815. It is an orally bioavailable CDK2/4/6 inhibitor with antineoplastic potential [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 125.8
Molecular weight 471.18
XLogP 2.18
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC(c1cc2cnc(nc2n(c1=O)C1CCCC1(C)O)NC1CCN(CC1)S(=O)(=O)C)F
Isomeric SMILES FC(c1cc2cnc(nc2n(c1=O)[C@@H]1CCC[C@@]1(C)O)NC1CCN(CC1)S(=O)(=O)C)F
InChI InChI=1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m1/s1
InChI Key QIEKHLDZKRQLLN-FOIQADDNSA-N
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
cyclin dependent kinase 6 Hs Inhibitor Inhibition 10.1 pKi - 1
pKi 10.1 (Ki 8x10-11 M) [1]
Description: Evaluated in a CDK6/Cyclin D1 mobility shift assay.
cyclin dependent kinase 2 Hs Inhibitor Inhibition 9.9 pKi - 1
pKi 9.9 (Ki 1.2x10-10 M) [1]
Description: Evaluated in a CDK2/Cyclin E1 mobility shift assay.
cyclin dependent kinase 4 Hs Inhibitor Inhibition 8.9 pKi - 1
pKi 8.9 (Ki 1.37x10-9 M) [1]
Description: Evaluated in a CDK4/Cyclin D3 mobility shift assay.